Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 155.4B | 146.1B | 156.9B | 147.1B |
| Cost of revenue | 83.3B | 76.4B | 83.1B | 78.6B |
| Gross profit | 72.1B | 69.7B | 73.8B | 68.5B |
| Operating expense | ||||
| Research & development | 14.4B | 13.7B | 14.5B | 14.0B |
| Selling general and admin | 19.6B | 18.6B | 22.9B | 19.3B |
| Other operating expenses | 7.7B | 7.5B | 8.5B | 8.0B |
| Operating income | 30.4B | 29.9B | 28.0B | 27.3B |
| Non operating interest income | ||||
| Income | 2.5B | 2.7B | 2.8B | 3.4B |
| Expense | 2.1B | 1.9B | 1.8B | 2.0B |
| Other income expense | -2.1B | -656.2M | -2.5B | -4.1B |
| Pretax income | 28.7B | 30.1B | 26.4B | 24.6B |
| Tax provision | 5.0B | 5.9B | 5.4B | 5.6B |
| Net income | 23.6B | 24.1B | 21.0B | 18.9B |
| Basic EPS | 1.3 | 1.3 | 1.1 | 1 |
| Diluted EPS | 1.3 | 1.3 | 1.1 | 1.0 |
| Basic average shares | 18.2B | 18.5B | 18.7B | 19.0B |
| Diluted average shares | 18.3B | 18.7B | 19.0B | 19.2B |
| EBITDA | 37.3B | 36.9B | 35.0B | 35.7B |
| Net income from continuing op. | 23.6B | 24.1B | 21.0B | 18.9B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |